IRIS Accounts Production v23.3.1.45 SC406680 Board of Directors 1.9.22 31.8.23 31.8.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC4066802022-08-31SC4066802023-08-31SC4066802022-09-012023-08-31SC4066802021-08-31SC4066802021-09-012022-08-31SC4066802022-08-31SC406680ns16:Scotland2022-09-012023-08-31SC406680ns15:PoundSterling2022-09-012023-08-31SC406680ns11:Director12022-09-012023-08-31SC406680ns11:PrivateLimitedCompanyLtd2022-09-012023-08-31SC406680ns11:Micro-entities2022-09-012023-08-31SC406680ns11:AuditExempt-NoAccountantsReport2022-09-012023-08-31SC406680ns11:FullAccounts2022-09-012023-08-31SC406680ns11:Director22022-09-012023-08-31SC406680ns11:RegisteredOffice2022-09-012023-08-31SC406680ns6:CurrentFinancialInstruments2023-08-31SC406680ns6:CurrentFinancialInstruments2022-08-31SC406680ns11:Director112022-08-31SC406680ns11:Director112021-08-31SC406680ns11:Director112022-09-012023-08-31SC406680ns11:Director112021-09-012022-08-31SC406680ns11:Director112023-08-31SC406680ns11:Director112022-08-31SC4066802ns11:Director22022-08-31SC4066802ns11:Director22021-08-31SC4066802ns11:Director22022-09-012023-08-31SC4066802ns11:Director22021-09-012022-08-31SC4066802ns11:Director22023-08-31SC4066802ns11:Director22022-08-31
REGISTERED NUMBER: SC406680 (Scotland)















Unaudited Financial Statements for the Year Ended 31 August 2023

for

Manning Medical Ltd

Manning Medical Ltd (by shares) (Registered number: SC406680)






Contents of the Financial Statements
for the Year Ended 31 August 2023




Page

Company Information 1

Statement of Financial Position 2


Manning Medical Ltd (by shares)

Company Information
for the Year Ended 31 August 2023







DIRECTORS: Dr J Manning
Mrs S Manning





REGISTERED OFFICE: Solstice
Redpath
EARLSTON
Berwickshire
TD4 6AD





REGISTERED NUMBER: SC406680 (Scotland)





ACCOUNTANTS: Douglas Home & Co Ltd
Chartered Accountants
47-49 The Square
Kelso
Roxburghshire
TD5 7HW

Manning Medical Ltd (by shares) (Registered number: SC406680)

Statement of Financial Position
31 August 2023

31/8/23 31/8/22
£    £    £    £   
FIXED ASSETS 327 437

CURRENT ASSETS 276,601 116,445

CREDITORS
Amounts falling due within one year (46,414 ) (24,695 )
NET CURRENT ASSETS 230,187 91,750
TOTAL ASSETS LESS CURRENT
LIABILITIES

230,514

92,187

CAPITAL AND RESERVES 230,514 92,187

NOTES TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2022 - 1 ) .

2. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 August 2023 and 31 August 2022:

31/8/23 31/8/22
£    £   
Dr J Manning
Balance outstanding at start of year 255 -
Amounts advanced 263 255
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 518 255

Mrs S Manning
Balance outstanding at start of year 45,554 -
Amounts advanced - 46,143
Amounts repaid (44,729 ) (589 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 825 45,554

During the year the company loaned the directors monies. At the year end the balance due was £1,342. There are no specific repayment terms and interest has been charged at an average rate of 2.5% per annum.



Manning Medical Ltd (by shares) (Registered number: SC406680)

Statement of Financial Position - continued
31 August 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 19 January 2024 and were signed on its behalf by:





Dr J Manning - Director